Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Most people carrying a smartphone on them at all times, as something of an extra appendage. The constant companion provides 24/7 access to online apps, games and social media, but how does it affect users' brains?
Texting a friend is one way to pass the time while walking or running on a treamill. But according to a study published in Computers in Human Behavior and Performance Enhancement & Health, using a cell phone during everyday activities can significantly affect postural stability.
The California Integrated Data Exchange (Cal INDEX) and Inland Empire Health Information Exchange (IEHIE) announced plans to merge, forming the largest nonprofit health information exchange (HIE) in California.
A CMS review of provider directories set up by Medicare Advantage plans found many listed the wrong phone numbers or locations for physicians or incorrectly labeled physicians as accepting new patients.
Surgeons can benefit greatly from high definition images during spinal, cranial and trauma procedures. Royal Phillips has developed an augmented-reality surgical navigation technology to guide surgeons through image-guided open and minimally-invasive spinal surgery.
How doctors feel about the Affordable Care Act (ACA) may depend largely on their age and existing political affiliation, putting them at odds with the stance of major medical organizations.
Researchers from the Complutense University of Madrid have developed a biosensor capable of detecting cancer antibodies in patients with colorectal and ovarian cancer.
Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.